Date of event
Thursday, September 29, 2022 - 1:00 pm -
Thursday, September 29, 2022 - 2:00 pm
Continuing Education Credits
Add to Calendar 2022-09-29 13:00:00 2022-09-29 14:00:00 Webinar: Interdisciplinary Care for the Management of NAFLD and NASH: A Team Sport AASLD America/New_York public

Content Contributor

Nonalcoholic Fatty Liver Disease SIG


  • Jeffrey V. Lazarus, MD
  • Monica A. Tincopa, MD


  • Albert Do, MD, MPH


Nonalcoholic fatty liver disease (NAFLD) is closely associated with metabolic syndrome, including obesity and diabetes. In addition, it is linked with a variety of deleterious hepatic and extrahepatic outcomes. This webinar will discuss the various manifestations of NAFLD and how they interface with a variety of medical and surgical disciplines including but not limited to hepatology, diabetology, lipidology, obesity medicine, bariatric and metabolic surgery. It will additionally demonstrate the multiple disciplines which may be incorporated in to a multidisciplinary NAFLD clinic to provide optimal care of patients.


Presenter Bios

Jeffrey V. Lazarus, MD

Prof Lazarus is head of the health systems team at the Barcelona Institute for Global Health (ISGlobal) and an Associate Professor at the Faculty of Medicine, University of Barcelona. In 2020, he was appointed a senior scholar CUNY Graduate School of Public health, where he leads the global COVID-19 vaccine hesitancy studies. He is Vice-Chairman of the board of the EASL International Liver Foundation, co-chair of the HIV Outcomes Coalition and a member of the Public Health and Policy Committee of the European Association for the Study of the Liver. He is the author of more than 250 publications including lead author of NAFLD: a consensus statement and the expert recommendation “Defining comprehensive models of care for NAFLD” (Nature Reviews GastroHep 2021), COVID-SCORE (Nature Medicine and PLOS ONE, 2020), The Lancet HIV series HIV outcomes beyond viral suppression (2019) and a working group chair of the EASL-Lancet Liver Commission (2021). He is co-chair of Innovations in NAFLD Care Workshop 2022 and in 2020, he joined The Lancet COVID-19 Commission public health taskforce and has been advising governments, NGOs and WHO, as well as frequently appearing in the media to address pressing issues about the pandemic. Prof Lazarus is an editorial board member of the International Journal of Drug Policy, HIV Medicine and the Journal of Hepatology. Previously, he worked for 11 years at WHO Europe and 3 at the Global Fund as well as founding director of Health Systems Global and board chair of the foundation AFEW International.

Photo of Dr. Jeffrey V. Lazarus


Monica Tincopa, MD MSc DABOM 

Monica Tincopa, MD, MSc, DABOM is a Transplant Hepatologist and Clinical Instructor of Medicine for UCLA Health Division of Digestive Diseases. Dr. Tincopa completed her medical school and internal medicine residency at Johns Hopkins University. She completed her gastroenterology and transplant hepatology fellowships at the University of Michigan (UM) in Ann Arbor. Dr. Tincopa also completed her master’s in health and health care Research at UM. She is board certified in internal medicine, gastroenterology, transplant hepatology and obesity medicine. Dr. Tincopa's area of expertise is focused on non-alcoholic fatty liver disease, non-alcoholic steatohepatitis (NASH), liver transplantation, health outcomes research and predictive modeling. She has served on AASLD Membership and Mentorship and Clinical Research Committees and was the recipient of a Blue Cross/Blue Shield Investigator Grant and AASLD Clinical and Translational Research Outcomes Award. Dr. Tincopa continues to publish on lifestyle interventions for NAFLD and NASH and clinical outcomes in liver transplant. 

Dr. Tincopa was the founder and director of the NAFLD clinic and program at UM and the Assistant Director of the UM Metabolic Fitness Program. She serves as a reviewer for multiple peer-reviewed journals including Hepatology, Liver Transplantation and the American Journal of Gastroenterology. Dr. Tincopa has presented her work at multiple national research conferences including Digestive Diseases Week, The Annual Liver Meeting and American Transplant Congress. As a clinician educator and research mentor, Dr. Tincopa has mentored numerous undergraduates, medical students, residents and fellows in clinical research and GI/Hepatology. She has recently published in Transplantation Direct, Therapeutic Advances in Gastroenterology and Liver Transplantation. 

Photo of Dr. Monica A. Tincopa


Moderator Bio

Albert Do, MD, MPH

Albert Do is an Assistant Professor of Medicine and Digestive Diseases at Yale University School of Medicine. He is the Clinical Director of the Yale Fatty Liver Disease Program, leading clinical expansion and program development of care in patients with suspected fatty liver diseases across the state of Connecticut. He has expertise in the management of chronic liver diseases particularly nonalcoholic fatty liver disease, alcohol-related liver disease, and secondary fatty liver diseases. He has trained in and is interested in the role of medical weight and metabolic health management interventions, as well as lifestyle factors affecting patients with liver disease and has published on a variety of topics in chronic liver diseases and obesity medicine. He is board certified in internal medicine, gastroenterology, obesity medicine, and lifestyle medicine.

Dr. Do is currently serving as member of the Clinical Guidelines Committee for the American Association for the Study of Liver Diseases (AASLD) and is involved in a variety of research studies including clinical epidemiology-based and multicenter clinical trials. He is involved in multiple committees at Yale, including leading the Patients and Families Advisory Committee for the Digestive Health Service Line, and the university-wide Information Technology Security Advisory Committee. He is an active educator and teacher, and has mentored trainees including medical students, residents, and fellows from Yale Schools of Medicine and Nursing, in clinical research projects and patient care.

Photo of Dr. Albert Do